anus disease: A non-neoplastic or neoplastic disorder that affects the anal canal or anal margin. Representative examples of non-neoplastic disorders include hemorrhoids and anal ulcer. Representative examples of neoplastic disorders include carcinoma, lymphoma, and melanoma. [database_cross_reference: NCIT:C26695]
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
908 |
4. Check minimum number of eventsNone |
908 |
5. Include endpointsNone |
908 |
6. Filter based on genotype QC (FinnGen only) |
908 |
Control definitions (FinnGen only)
- Control exclude
- N14_FEMALEGENINF
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Ulcer of vagina/vulva
based on the number of shared cases.
Similar with more cases:
- Inflammatory diseases of female pelvic organs
- Genitourinary diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5605 | 5605 | - |
| Only index persons | 5168 | 5168 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.16 | 0.16 | - |
| Only index persons | 0.19 | 0.19 | - |
| Median age at first event (years) | |||
| Whole population | - | 46.23 | - |
| Only index persons | - | 48.21 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 908 | 908 | - |
| Unadjusted period prevalence (%) | 0.31 | 0.31 | - |
| Median age at first event (years) | 52.29 | 52.29 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 772
- Matched controls
- 7720
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N76.6
ICD-10 Finland
Ulceration of vulva
1114.8
323.0
542
16
N76.5
ICD-10 Finland
Ulceration of vagina
1224.2
272.2
250
*
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
24.8
141.2
205
111
ULA02
NOMESCO Finland
Kolposcopy
6.6
91.6
276
597
D07AD01
ATC
clobetasol; topical
4.6
55.9
230
656
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
3.4
54.3
415
1988
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
11.1
51.5
101
103
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
3.8
44.6
223
741
LEB00
NOMESCO Finland
Biopsy of vagina
11.6
40.5
77
73
J02AC01
ATC
fluconazole; systemic
2.7
37.6
470
2833
N76.3
ICD-10 Finland
Subacute and chronic vulvitis
31.4
27.4
36
12
P01AB01
ATC
metronidazole; oral, rectal
2.2
24.3
369
2250
D07AB02
ATC
hydrocortisone butyrate; topical
2.3
23.5
274
1468
N76.0
ICD-10 Finland
Acute vaginitis
4.0
22.2
94
259
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
22.1
344
2093
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
14.6
21.0
35
25
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.7
20.4
158
673
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
7.2
19.8
48
70
N76.2
ICD-10 Finland
Acute vulvitis
41.3
19.6
24
6
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.4
19.4
204
1021
E0000UV
ATC
NA
2.0
18.6
360
2341
J05AB11
ATC
valaciclovir; oral
2.7
18.5
140
584
LFC00
NOMESCO Finland
Partial excision of vulva
29.6
17.5
23
8
G01AA10
ATC
clindamycin; vaginal
2.3
16.9
189
968
LCA06
NOMESCO Finland
Biopsy of endometrium
2.5
16.9
147
662
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.9
16.2
431
3095
D07AC01
ATC
betamethasone; topical
2.0
15.6
276
1703
A60.0
ICD-10 Finland
Herpesviral infection of genitalia and urogenital tract
7.1
15.3
37
54
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
15.3
239
1402
J01DB01
ATC
cefalexin; oral
2.1
14.9
641
5398
8070/3-C51.9
ICD-O-3
Squamous cell carcinoma, NOS, of vulva, NOS
57.8
14.8
17
*
H02AB06
ATC
prednisolone; systemic
1.8
14.6
356
2449
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
14.3
143
689
A02BC02
ATC
pantoprazole; systemic
1.8
14.1
480
3667
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.3
13.9
134
634
N76.8
ICD-10 Finland
Other specified inflammation of vagina and vulva
11.7
13.9
25
22
C51.01
ICD-10 Finland
Squamous cell carcinoma of the labium majus
76.5
13.6
15
*
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
2.7
13.1
97
395
M35.2
ICD-10 Finland
Behçet disease
+∞
12.5
12
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
12.5
94
389
J05AB01
ATC
aciclovir; systemic
2.0
12.4
199
1167
C05AA08
ATC
fluocortolone; rectal, topical
2.3
12.2
116
541
N76.1
ICD-10 Finland
Subacute and chronic vaginitis
6.0
12.2
33
57
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
12.1
203
1210
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
11.7
288
1945
M25.5
ICD-10 Finland
Pain in joint
1.8
11.4
240
1539
L43.9
ICD-10 Finland
Lichen planus, unspecified
6.1
11.3
30
51
J01MA02
ATC
ciprofloxacin; systemic
1.8
11.0
268
1796
UKC02
NOMESCO Finland
Cystoscopy
2.5
11.0
88
375
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
7.6
11.0
25
34
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
2.2
11.0
120
599
TLC00
NOMESCO Finland
Insertion of intrauterine device
2.7
10.9
78
311
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
10.9
287
1969
L29.2
ICD-10 Finland
Pruritus vulvae
5.5
10.8
31
58
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
10.7
203
1251
N94.1
ICD-10 Finland
Dyspareunia
5.2
10.6
32
64
N06AX11
ATC
mirtazapine; oral
1.8
10.6
252
1674
X15
ICPC
Vaginal symptom/complaint other
3.0
10.3
60
212
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
10.3
289
2015
UJF32
NOMESCO Finland
Coloscopy
1.9
10.3
176
1048
N90.8
ICD-10 Finland
Other specified noninflammatory disorders of vulva and perineum
10.2
10.1
19
19
C51.11
ICD-10 Finland
Squamous cell carcinoma of the labium minus
40.6
10.0
12
*
N02BE01
ATC
paracetamol; systemic, rectal
1.9
10.0
655
5775
J01FF01
ATC
clindamycin; systemic
1.8
9.9
192
1188
N90.2
ICD-10 Finland
Severe vulvar dysplasia, not elsewhere classified
17.0
9.9
15
9
N02AX02
ATC
tramadol; systemic, rectal
1.7
9.7
275
1909
R01AD09
ATC
mometasone; nasal
1.6
9.6
362
2718
N77.1*B37.3
ICD-10 Finland
Candidiasis of vulva and vagina
5.3
9.6
28
54
LC2HE
NOMESCO Finland
Hystero-salpingography with ultrasound
2.9
9.5
59
217
E000006
ATC
NA
2.5
9.5
76
326
U02
ICPC
Urinary frequency/urgency
2.0
9.2
133
742
N90.9
ICD-10 Finland
Noninflammatory disorder of vulva and perineum, unspecified
7.9
9.2
20
26
A02BC03
ATC
lansoprazole; oral
1.7
9.2
202
1301
N03AX16
ATC
pregabalin; oral
1.8
9.1
171
1045
N73.9
ICD-10 Finland
Female pelvic inflammatory disease, unspecified
7.6
9.0
20
27
N30.0
ICD-10 Finland
Acute cystitis
1.9
8.9
141
812
N95.0
ICD-10 Finland
Postmenopausal bleeding
2.3
8.9
88
417
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
3.4
8.9
42
129
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.8
8.8
186
1178
N06AX21
ATC
duloxetine; oral
2.2
8.8
94
461
N30
ICD-10 Finland
Cystitis
2.3
8.8
85
399
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
8.8
376
2893
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
2.6
8.7
62
248
R51.80
ICD-10 Finland
Headache
1.9
8.7
139
802
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
8.7
259
1812
WX400
NOMESCO Finland
Inhalation anesthesy
3.0
8.7
49
168
J01EA01
ATC
trimethoprim; systemic
1.7
8.7
235
1601
B37.3
ICD-10 Finland
Candidiasis of vulva and vagina
4.7
8.7
28
61
J01CA08
ATC
pivmecillinam; oral
1.6
8.6
416
3291
61610
ICD-8 Finland
Diseases of parametrium and pelvic peritoneum (female), Pelvic peritoneal adhesions, female
+∞
8.3
8
*
ZXE00
NOMESCO Finland
One hour or less
1.6
8.3
308
2275
M01AH05
ATC
etoricoxib; oral
1.6
8.1
411
3269
8077/2-C51.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vulva, NOS
33.7
8.1
10
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.0
8.0
99
517
U07
ICPC
Urine symptom/complaint other
2.7
8.0
54
208
S31.4
ICD-10 Finland
Open wound of vagina and vulva
22.3
8.0
11
5
J01FA10
ATC
azithromycin; systemic
1.6
8.0
481
3978
R06AX27
ATC
desloratadine; oral
1.6
7.9
235
1637
N95.2
ICD-10 Finland
Postmenopausal atrophic vaginitis
2.5
7.8
61
259
Z2221
NOMESCO Finland
Medical doctor
1.6
7.8
227
1568
N76.4
ICD-10 Finland
Abscess of vulva
10.9
7.8
14
13
L43.8
ICD-10 Finland
Other lichen planus
4.5
7.8
26
59
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.6
7.6
53
212
LWW96
NOMESCO Finland
Other reoperation in gynaecological surgery
12.0
7.6
13
11
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
7.6
210
1432
C51.9
ICD-10 Finland
Malignant neoplasm: Vulva, unspecified
25.3
7.6
10
*
JAH01
NOMESCO Finland
Laparoscopy
2.9
7.4
44
160
A02BC05
ATC
esomeprazole; systemic
1.6
7.4
284
2105
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.1
7.3
78
385
AA1AD
NOMESCO Finland
CT of head and brain
1.8
7.3
142
872
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.8
7.3
139
850
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
7.3
199
1352
K60.2
ICD-10 Finland
Anal fissure, unspecified
5.9
7.3
19
33
N75.1
ICD-10 Finland
Abscess of Bartholin gland
15.9
7.2
11
7
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
7.2
93
495
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
7.2
258
1875
B00.9
ICD-10 Finland
Herpesviral infection, unspecified
8.9
7.1
14
16
E000001
ATC
NA
1.7
6.9
170
1119
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.5
6.9
30
88
H02AB04
ATC
methylprednisolone; systemic
1.9
6.9
104
590
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.9
6.8
98
544
N81.1
ICD-10 Finland
Cystocele
2.1
6.8
72
355
N39.3
ICD-10 Finland
Stress incontinence
2.1
6.7
71
348
L02
ICPC
Back symptom/complaint
2.0
6.7
86
459
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
6.7
164
1078
M35.7
ICD-10 Finland
Hypermobility syndrome
4.5
6.7
22
50
LEG12
NOMESCO Finland
Transobturatoric tape
4.5
6.7
22
50
N77.1
ICD-10 Finland
Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere
6.5
6.7
16
25
G04BD08
ATC
solifenacin; oral
2.5
6.6
50
209
M79.6
ICD-10 Finland
Pain in limb
1.5
6.6
264
1960
K30
ICD-10 Finland
Functional dyspepsia
2.0
6.6
87
469
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.3
6.5
58
265
R33
ICD-10 Finland
Retention of urine
3.5
6.5
28
82
X29
ICPC
Genital sympt/compl female other
4.3
6.5
22
52
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.9
6.4
89
485
N77.1*A60.0
ICD-10 Finland
Vaginitis, vulvitis and vulvovaginitis in herpesviral [herpes simplex] infection
14.4
6.4
10
7
R5140
NOMESCO Finland
Monitoring the use of the aid
2.3
6.3
56
252
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
5.2
6.3
18
35
R03AC02
ATC
salbutamol; inhalant
1.5
6.3
401
3275
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
6.3
240
1760
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
2.1
6.3
66
324
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
6.3
133
838
L15
ICPC
Knee symptom/complaint
1.6
6.3
154
1014
C51.00
ICD-10 Finland
Malignant tumor of the labium majus without histology
+∞
6.3
6
*
61207
ICD-8 Finland
Acute salpingitis and oophoritis, suspecta
+∞
6.3
6
*
N77.8*M35.2
ICD-10 Finland
Ulceration of vulva in Behçet's disease
+∞
6.3
6
*
J01FA06
ATC
roxithromycin; oral
1.5
6.3
285
2174
M54.5
ICD-10 Finland
Low back pain
1.5
6.2
250
1853
LEE00
NOMESCO Finland
Suture of vagina
26.9
6.2
8
*
C51.81
ICD-10 Finland
Squamous cell carcinoma of the vulva
26.9
6.2
8
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.9
6.2
97
556
R42
ICD-10 Finland
Dizziness and giddiness
1.7
6.2
149
973
J01MA12
ATC
levofloxacin; systemic
1.8
6.2
107
635
B01AB05
ATC
enoxaparin; parenteral
1.6
6.2
200
1413
D07CC01
ATC
betamethasone and antibiotics; topical
1.8
6.2
98
565
R06.0
ICD-10 Finland
Dyspnoea
1.6
6.2
174
1186
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.8
6.1
99
573
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.7
6.1
39
147
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
6.1
64
313
K12.00
ICD-10 Finland
Recurrent oral aphthae
4.4
6.1
20
46
M01AB05
ATC
diclofenac; systemic, rectal
1.5
6.0
452
3805
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
57
82
7.35
38.10
1.3
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
385
2158
2.36
33.77
1.7
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
501
3184
2.28
32.13
2.7
2.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
189
780
2.80
31.45
2.0
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
72
172
4.46
28.00
1.7
1.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
390
2439
2.05
23.80
3.5
3.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
694
5375
2.24
23.28
6.8
4.3
e6/l
2050.5
3094.1
—
8
69
(3026008) Bacteria identified in Urine by Culture
412
2649
2.02
23.07
3.9
2.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
384
2416
2.02
22.79
6.3
5.6
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
21
17
12.62
21.25
1.0
1.0
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
21
17
12.62
21.25
2.1
2.4
ug/l
1.9
2.1
—
16
8
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
345
2148
1.98
20.59
2.3
2.2
u/l
54.0
56.5
0.77
306
1955
(3009261) Glucose [Presence] in Urine by Test strip
547
4000
1.92
19.87
4.7
3.6
estimate
0.0
0.0
0.50
110
752
(3037467) Urinalysis macro (dipstick) panel - Urine
693
5520
2.08
19.31
6.1
4.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
542
3974
1.90
19.28
6.1
4.8
estimate
0.0
0.0
0.50
111
763
(3002582) Erythrocytes [#/volume] in Urine
327
2070
1.91
18.06
3.5
2.9
e6/l
40.6
69.8
0.63
258
1547
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
692
5576
2.01
17.71
7.9
6.5
u/l
73.6
74.9
0.49
655
5209
(3018095) Leukocytes [#/volume] in Urine
387
2606
1.85
17.45
4.4
3.4
e6/l
55.3
87.2
1.47
273
1689
(3019198) Lymphocytes [#/volume] in Blood
525
3890
1.83
17.21
6.7
5.4
e9/l
2.0
2.0
0.20
467
3471
(3022096) Basophils/100 leukocytes in Blood
472
3388
1.82
17.17
6.8
5.6
%
0.7
0.7
0.16
436
3155
(3001604) Monocytes [#/volume] in Blood
510
3753
1.82
17.03
6.7
5.4
e9/l
0.5
0.5
0.33
439
3287
(3030467) Casts [#/volume] in Urine by Automated count
304
1910
1.89
16.97
3.5
2.8
e6/l
0.2
0.4
1.90
233
1413
(3006504) Eosinophils/100 leukocytes in Blood
485
3520
1.81
16.91
6.6
5.5
%
2.9
2.7
1.10
451
3276
(3002030) Lymphocytes/100 leukocytes in Blood
500
3670
1.81
16.72
6.7
5.5
%
29.8
29.3
0.47
466
3428
(3006315) Basophils [#/volume] in Blood
510
3766
1.81
16.71
6.7
5.5
e9/l
0.0
0.0
0.11
440
3295
(3013115) Eosinophils [#/volume] in Blood
524
3905
1.81
16.60
6.9
5.7
e9/l
0.2
0.2
0.52
468
3474
(3035350) Ketones [Presence] in Urine by Test strip
527
3952
1.79
16.17
4.7
3.5
estimate
0.0
0.0
0.00
111
754
(3019069) Monocytes/100 leukocytes in Blood
484
3543
1.78
16.10
6.8
5.7
%
8.2
8.1
0.40
451
3324
(3013650) Neutrophils [#/volume] in Blood by Automated count
570
4383
1.81
15.98
9.2
8.2
e9/l
3.9
3.9
0.01
508
3874
(3024561) Albumin [Mass/volume] in Serum or Plasma
420
2955
1.78
15.95
4.5
4.0
g/l
35.9
36.0
0.12
386
2727
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
438
3127
1.77
15.76
4.9
4.8
mmol/l
1.2
1.2
0.32
396
2821
(3028679) Herpes simplex virus Ab [Presence] in Serum
26
42
6.34
15.54
1.3
1.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
690
5651
1.92
15.52
5.1
3.9
mm/h
12.1
11.5
0.55
647
5225
(3048689) Calprotectin [Mass/mass] in Stool
193
1070
2.02
15.39
2.4
2.3
ug/g
148.9
106.3
0.60
155
820
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
157
810
2.13
15.17
2.2
1.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
489
3632
1.75
15.08
6.3
5.3
%
55.7
56.7
1.18
456
3402
(36304419) Bacteria [Presence] in Urine
295
1896
1.82
14.97
3.5
2.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
487
3620
1.74
14.92
5.2
5.1
umol/l
9.4
10.1
1.50
454
3406
(3042936) Bacteria identified in Isolate by Culture
168
897
2.07
14.80
2.0
1.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
97
414
2.50
14.58
1.6
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
228
1362
1.90
14.53
2.9
2.6
mosm/kgh2o
506.0
522.9
0.53
189
1165
(3037522) Nuclear Ab [Titer] in Serum
189
1074
1.96
13.92
1.5
1.3
titre
474.0
641.3
0.60
40
238
(3026389) Candida sp identified in Specimen by Organism specific culture
41
109
3.89
13.82
1.4
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
462
3443
1.70
13.52
5.6
5.5
mmol/l
1.2
1.2
0.07
375
2895
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
856
7719
2.90
13.48
16.3
11.5
mg/l
20.1
20.1
0.00
705
5944
(3000850) Epithelial cells [#/volume] in Urine
236
1456
1.84
13.46
2.7
2.4
e6/l
7.8
9.2
0.63
198
1288
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
182
1034
1.95
13.37
2.5
1.9
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
298
1976
1.76
13.31
2.1
2.1
u/l
110.2
177.7
1.29
278
1860
(3015736) pH of Urine
420
3076
1.68
12.93
4.2
3.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
181
1038
1.93
12.90
3.2
2.6
e6/l
4.7
4.5
0.07
108
509
(3033658) Prothrombin time (PT) actual/Normal
268
1742
1.76
12.73
4.0
3.4
%
95.7
94.7
0.28
256
1680
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
25
48
5.33
12.54
2.4
1.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
395
2886
1.65
12.00
2.2
1.9
pmol/l
101.3
97.5
0.69
207
1427
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
241
1542
1.77
11.99
2.6
2.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
309
2122
1.69
11.89
4.0
3.4
ph
7.4
7.4
0.37
67
399
(40768443) Skin Pathology biopsy report
73
305
2.52
11.46
1.4
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
264
1754
1.71
11.40
1.9
1.7
mg/l
0.8
1.0
2.08
197
1314
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
598
4904
1.64
11.01
3.1
2.7
u/l
35.7
35.8
0.01
554
4606
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
217
1384
1.75
10.77
2.5
2.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
46
156
3.05
10.71
4.2
3.7
%
56.6
58.4
0.42
46
156
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
185
1131
1.80
10.61
3.2
2.4
e6/l
1.5
1.1
0.29
112
598
(3011397) Hemoglobin [Presence] in Urine by Test strip
270
1841
1.66
10.43
4.6
3.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
514
4107
1.58
10.15
4.1
3.9
mmol/l
6.3
6.4
0.51
476
3704
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
331
2390
1.61
10.09
3.7
3.2
ng/l
27.8
45.9
0.47
190
1419
(3030905) Polymorphonuclear cells [#/volume] in Blood
44
151
3.01
10.05
4.2
3.5
e9/l
4.0
4.3
0.35
44
151
(3019550) Sodium [Moles/volume] in Serum or Plasma
838
7645
2.25
9.96
16.6
12.7
mmol/l
139.5
139.6
0.06
825
7417
(3007164) IgA [Mass/volume] in Serum or Plasma
254
1727
1.65
9.83
1.6
1.5
g/l
2.2
2.2
0.08
150
1010
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
23
51
4.60
9.81
1.2
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
127
706
1.93
9.78
1.8
2.1
nmol/l
379.1
383.3
0.08
116
646
(3023103) Potassium [Moles/volume] in Serum or Plasma
838
7665
2.21
9.55
16.8
12.8
mmol/l
3.9
3.9
0.66
823
7416
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
326
2372
1.58
9.50
3.4
2.8
u/l
27.1
28.1
0.39
303
2250
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
746
6584
1.75
9.34
5.1
4.4
pmol/l
14.6
14.6
0.03
697
6034
(3023368) Bacteria identified in Blood by Culture
232
1562
1.65
9.26
4.1
3.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
220
1462
1.67
9.23
1.3
1.3
iu/ml
22.2
31.1
0.97
64
458
(40768797) Stomach Pathology biopsy report
164
1006
1.77
9.20
1.3
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
131
752
1.87
9.13
2.6
2.5
umol/l
4.9
5.8
0.75
111
619
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
395
3022
1.54
9.12
4.9
3.7
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
165
1017
1.76
9.10
3.0
2.9
mmol/l
0.8
0.8
0.15
153
944
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
212
1405
1.66
8.96
1.4
1.2
u/ml
6.8
11.7
0.90
79
545
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
187
1207
1.69
8.71
3.2
3.5
ng/l
44.6
345.4
3.19
123
826
(3032080) INR in Blood by Coagulation assay
333
2485
1.54
8.45
9.0
7.5
inr
1.1
1.1
0.02
115
784
(3015377) Calcium [Moles/volume] in Serum or Plasma
341
2558
1.53
8.44
3.1
3.2
mmol/l
2.3
2.4
1.81
298
2250
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
33
5.23
8.43
1.0
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
91
478
2.00
8.24
1.3
1.3
iu/l
25.0
23.6
0.13
78
413
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
102
560
1.93
8.13
3.1
3.3
u/ml
26.2
60.4
2.07
93
536
(3021589) Normoblasts [#/volume] in Blood
434
3446
1.50
8.10
10.9
8.3
e9/l
0.0
0.0
0.04
362
2823
(3019309) Folate [Moles/volume] in Red Blood Cells
189
1246
1.65
8.07
1.7
1.7
nmol/l
1212.6
1197.4
0.08
155
926
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
864
8078
2.44
8.05
12.2
9.2
u/l
23.1
22.9
0.16
841
7781
(40758558) Short blood count panel - Blood
270
1944
1.55
7.97
6.6
6.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
148
918
1.73
7.93
2.3
2.1
g/l
2.4
2.4
0.22
134
848
(3000494) Fungus identified in Specimen by Culture
135
819
1.76
7.81
1.6
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
284
2083
1.53
7.65
1.4
1.3
u/ml
0.6
2.0
3.04
75
543
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
86
458
1.97
7.49
1.6
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
267
1940
1.53
7.48
2.0
1.6
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
159
1022
1.67
7.45
2.2
2.1
umol/l
13.2
13.5
0.18
147
937
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
51
224
2.35
7.23
1.4
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
425
3411
1.46
7.23
2.5
2.3
nmol/l
82.1
77.4
2.45
393
3077
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
135
841
1.71
7.09
2.5
2.2
%
22.3
22.3
0.00
118
709
(3001964) Herpes simplex virus Ag [Presence] in Specimen
14
27
5.25
6.98
1.4
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
578
4939
1.47
6.98
3.9
3.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
124
759
1.73
6.94
1.3
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
59
281
2.18
6.93
1.8
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
39
155
2.58
6.85
1.1
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
457
3744
1.44
6.84
4.6
3.9
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
147
947
1.66
6.80
2.5
2.0
s
30.5
29.2
1.67
138
916
(3025941) Bacteria identified in Stool by Culture
82
446
1.92
6.73
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
36
4.51
6.72
1.0
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
158
1040
1.63
6.71
1.6
1.5
—
—
—
0
0
(4306422)
32
116
2.82
6.70
1.1
1.2
—
—
—
0
0
(4035726)
104
611
1.79
6.70
1.5
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
38
151
2.58
6.68
2.4
2.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
289
2189
1.47
6.46
4.0
3.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
282
2129
1.47
6.40
5.4
3.8
estimate
0.0
0.0
1.08
107
763
(46235355) HIV 1 and 2 tests - Meaningful Use set
285
2157
1.47
6.38
2.3
2.0
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
41
173
2.43
6.37
1.0
1.4
mmol/l
3.7
3.7
0.04
36
162
(3005322) IgE [Units/volume] in Serum or Plasma
95
554
1.80
6.27
1.5
1.2
u/ml
1200.9
219.5
0.47
90
510
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
48
219
2.26
6.27
1.2
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
807
7474
1.72
6.16
6.3
5.2
mu/l
1.8
2.0
0.84
768
6941
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
39
164
2.44
6.12
1.4
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
48
222
2.23
6.08
1.8
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
18
49
3.73
5.94
2.1
2.0
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
108
667
1.70
5.84
3.6
4.4
u/l
225.2
251.4
1.19
100
626
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
40
174
2.36
5.84
1.1
1.4
e6/l
28.9
10.0
0.38
24
136
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
40
174
2.36
5.84
1.2
1.5
e6/l
1229.3
123.3
0.50
26
144
(3005719) IgG [Mass/volume] in Serum or Plasma
90
528
1.78
5.83
3.0
3.0
g/l
11.1
10.3
0.99
82
476
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
255
1917
1.46
5.83
2.3
2.1
mg/l
2.9
2.9
0.05
223
1615
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
20
5.56
5.81
1.2
1.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
859
8129
2.05
5.80
15.4
10.9
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
47
222
2.18
5.67
2.2
2.7
%
173.3
178.9
0.16
41
211
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
78
445
1.82
5.54
2.0
1.7
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
82
476
1.79
5.51
2.3
2.6
g/l
68.1
66.8
0.96
76
436
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
148
1005
1.56
5.48
1.8
1.8
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
18
53
3.44
5.32
1.8
2.0
%
11.8
11.3
0.07
13
31
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
12
26
4.66
5.27
1.2
1.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
74
423
1.82
5.23
1.4
1.6
mu/l
397.3
299.7
0.83
62
367
(3001122) Ferritin [Mass/volume] in Serum or Plasma
468
3970
1.37
5.14
3.6
2.8
ug/l
71.6
73.4
0.14
443
3666
(40761535) Cells panel - Urine sediment
90
549
1.71
5.10
4.0
3.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
31
128
2.47
5.09
2.7
3.1
mmol/l
3.4
2.8
0.25
17
88
(3019150) Specific gravity of Urine by Refractometry
226
1705
1.43
4.97
4.7
3.9
kg/l
1.0
1.0
0.01
31
260
(3008898) HLA-B27 [Presence]
60
327
1.89
4.94
1.1
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
765
7082
1.51
4.84
14.2
10.6
ml/min/173m2
86.2
85.5
0.37
647
5648
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
721
6603
1.45
4.77
5.5
5.0
mmol/mol
38.4
38.5
0.13
677
6130
(3021960) Folate [Moles/volume] in Serum or Plasma
216
1631
1.43
4.70
1.6
1.4
nmol/l
22.0
22.1
0.03
191
1391
(3016018) Differential panel - Cerebral spinal fluid
21
74
2.88
4.68
1.2
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
22
80
2.79
4.64
1.3
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
82
501
1.70
4.63
2.6
2.3
e9/l
4.0
4.0
0.05
62
412
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
183
1344
1.45
4.62
3.3
2.6
mmol/l
2.5
2.4
0.08
161
1182
(3044640) Blood type and Crossmatch panel - Blood
297
2387
1.36
4.43
2.5
2.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
18
60
3.04
4.41
1.1
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
107
710
1.57
4.37
1.7
1.7
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
892
8648
2.78
4.34
25.0
17.5
e9/l
262.1
263.0
0.16
883
8439
(3002385) Erythrocyte distribution width [Ratio]
728
6718
1.42
4.28
20.1
14.3
%
13.5
13.5
0.23
721
6569
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
87
552
1.64
4.27
2.4
2.4
au/ml
54.2
24.1
—
9
33
(3027945) Reticulocytes/100 erythrocytes in Blood
100
657
1.59
4.26
2.4
2.9
%
1.7
1.8
0.59
86
581
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
103
684
1.57
4.20
2.2
2.2
u/l
28.4
35.5
1.47
87
571
(3026361) Erythrocytes [#/volume] in Blood
892
8655
2.74
4.19
24.9
17.5
e12/l
4.4
4.4
0.51
879
8428
(3051611) Lipemic interference index of Serum or Plasma
18
62
2.94
4.19
3.1
3.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
231
1797
1.38
4.18
4.7
4.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
774
7232
1.48
4.17
4.5
4.1
mmol/l
5.7
5.7
0.00
722
6615
(3000060) B lymphocytes [#/volume] in Blood
11
27
4.11
4.17
1.6
1.9
e6/l
261.7
225.0
—
6
16
(3021879) Hepatitis B virus core Ab [Presence] in Serum
101
669
1.57
4.16
1.3
1.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
892
8658
2.72
4.13
25.0
17.5
e9/l
6.6
6.7
0.16
880
8425
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
48
260
1.89
4.06
2.0
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
105
706
1.55
4.06
1.7
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
105
706
1.55
4.06
5.7
3.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
45
239
1.93
4.04
1.2
1.3
u/l
14.8
11.8
0.43
36
196
(4010399)
77
482
1.65
4.00
1.4
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
29
132
2.24
3.90
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
30
139
2.20
3.87
1.3
1.2
u/ml
7.0
5.4
0.11
14
61
(3009445) Proteinase 3 Ab [Units/volume] in Serum
47
258
1.87
3.84
1.2
1.7
—
11.6
—
0
6
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
103
700
1.53
3.80
2.9
2.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
772
7241
1.44
3.77
18.1
12.8
%
39.2
39.0
0.35
573
5441
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
32
157
2.08
3.59
2.9
4.1
mg/l
33.9
52.2
0.36
22
123
(3034860) Kappa light chains.free [Mass/volume] in Serum
32
157
2.08
3.59
2.9
4.1
mg/l
28.4
40.1
1.16
22
124
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
91
610
1.55
3.58
2.3
2.2
u/l
1441.5
6104.3
2.98
31
267
(40767503) Oxygen content in Capillary blood by calculation
27
125
2.20
3.51
2.7
2.1
%
16.7
15.8
0.54
11
56
(3052851) Hemolysis interference index of Serum or Plasma
39
208
1.91
3.49
3.1
2.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
66
412
1.65
3.49
2.3
2.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
113
804
1.46
3.35
1.6
1.5
%
1.4
1.3
0.22
99
713
(3036489) Thrombin time
48
278
1.77
3.33
1.9
2.3
s
21.0
20.7
0.22
41
247
(3009508) Creatinine [Moles/volume] in Urine
247
2003
1.32
3.32
3.0
3.1
mmol/l
6.5
6.8
0.39
212
1695
(3023419) Bacteria identified in Sputum by Culture
18
71
2.57
3.31
1.4
2.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
87
589
1.53
3.28
3.4
2.9
mmol/l
1.2
1.2
0.16
76
495
(3028707) Methadone [Presence] in Urine by Screen method
35
184
1.94
3.28
1.9
2.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
13
43
3.05
3.26
1.1
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
32
164
1.99
3.22
1.2
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
130
957
1.42
3.22
1.2
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
28
3.60
3.20
1.0
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
193
1519
1.34
3.18
1.6
1.7
pmol/l
39103035.1
27316740.2
0.11
156
1252
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
87
596
1.51
3.12
3.4
3.3
pmol/l
4.4
4.5
1.07
78
533
(1616796) Gas panel - Central venous blood
26
125
2.11
3.11
4.2
2.7
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
14
50
2.83
3.09
1.4
1.7
—
47.8
—
0
5
(3028026) IgM [Mass/volume] in Serum or Plasma
65
418
1.60
3.08
2.0
1.8
g/l
1.3
1.4
0.26
59
376
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
210
1681
1.32
3.08
3.0
2.9
ng/l
913.2
1033.9
0.30
174
1394
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
12
5.87
3.02
1.3
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
30
155
1.97
2.97
1.5
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
67
438
1.57
2.97
1.1
1.1
—
185.0
—
0
11
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
618
5676
1.28
2.96
4.1
3.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
36
199
1.84
2.93
1.5
1.4
ug/g
287.1
312.4
0.20
14
115
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
69
456
1.56
2.92
2.9
2.8
ng/l
105.1
198.4
3.04
60
418
(3016650) Hepatitis A virus Ab [Presence] in Serum
24
115
2.12
2.90
1.1
1.0
—
—
—
0
0
(3013512) EKG study
231
1889
1.30
2.88
3.8
3.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
44
260
1.73
2.88
1.3
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
28
143
1.99
2.87
1.3
1.2
u/ml
11.3
3.1
—
7
50
(4268621)
21
96
2.22
2.85
2.4
2.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
189
1506
1.32
2.85
1.8
1.7
—
—
—
0
0
(4198724)
11
36
3.08
2.81
1.4
2.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
9
23
3.94
2.78
1.1
1.1
%
89.6
99.1
—
9
23
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
9
23
3.94
2.78
1.1
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
27
138
1.99
2.77
1.4
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
67
448
1.54
2.71
2.2
2.4
ug/l
5.7
5.8
0.02
53
389
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
37
213
1.77
2.67
2.0
2.8
g/l
3.6
3.7
0.20
32
206
(3048929) Epstein Barr virus Ab [Presence] in Serum
47
290
1.65
2.65
1.6
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
69
469
1.51
2.60
2.6
2.7
e9/l
69.4
73.7
0.40
46
354
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
19
87
2.21
2.58
1.2
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
35
201
1.77
2.55
2.4
2.4
g/l
0.4
0.7
0.41
30
179
(4211845)
12
44
2.75
2.55
5.7
2.7
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
7
7.18
2.55
1.0
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
231
1918
1.27
2.53
1.7
1.6
mmol/l
1.3
1.3
0.00
194
1632
(3013139) Helicobacter pylori Ag [Presence] in Stool
80
564
1.46
2.53
1.3
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
55
360
1.56
2.46
2.5
2.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
45
281
1.63
2.44
5.6
8.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
222
1844
1.27
2.42
3.8
4.0
mg/mmol
8.3
7.9
0.04
121
1086
(3012516) Albumin [Mass/volume] in Urine
212
1752
1.27
2.41
3.1
3.2
mg/l
1250.1
317.3
0.73
115
1042
(3003458) Phosphate [Moles/volume] in Serum or Plasma
106
794
1.38
2.40
4.0
4.4
mmol/l
1.0
1.0
0.06
100
718
(1617658) Protocol used for examination of sentinel lymph nodes
19
90
2.13
2.40
1.3
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
128
988
1.34
2.40
1.6
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
27
146
1.88
2.39
1.3
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
11
40
2.77
2.38
6.1
2.8
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
7
17
4.14
2.36
1.0
1.2
—
71.8
—
0
5
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
7
17
4.14
2.36
1.0
1.1
—
90.4
—
0
5
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
221
1840
1.27
2.36
1.7
1.7
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
32
184
1.77
2.34
1.3
1.5
nmol/l
0.5
0.4
0.21
24
154
(3014765) Yersinia sp identified in Stool by Organism specific culture
42
261
1.64
2.33
1.2
1.1
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
20
98
2.06
2.33
1.4
1.8
mmol/l
1.5
1.7
0.84
20
98
(3000991) Gas panel - Venous blood
68
473
1.47
2.31
6.3
6.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
86
627
1.41
2.29
5.0
6.2
mmol/l
0.7
1.2
0.63
64
503
(4062490)
16
72
2.24
2.28
2.2
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
12
47
2.57
2.27
1.1
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
134
1050
1.32
2.27
1.9
1.9
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
22
113
1.97
2.27
1.3
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
15
66
2.29
2.25
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
15
66
2.29
2.25
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
15
66
2.29
2.25
1.3
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
101
759
1.37
2.25
1.2
1.2
iu/ml
190.2
148.1
0.29
35
310
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
18
86
2.12
2.24
1.2
1.2
nmol/l
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
9
29
3.12
2.23
1.3
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
98
735
1.37
2.21
1.2
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
83
606
1.41
2.20
2.1
2.1
g/l
0.2
0.2
1.39
77
568
(3028433) Virus identified in Specimen by Culture
8
24
3.35
2.18
1.1
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
76
548
1.42
2.16
2.5
3.4
ng/l
82.0
77.4
0.18
63
474
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
41
259
1.61
2.16
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
42
267
1.60
2.15
1.2
1.2
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
14
4.31
2.15
1.0
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
220
1.66
2.15
2.2
2.2
g/l
10.2
9.9
0.13
30
193
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
228
1.65
2.14
2.2
2.2
g/l
7.6
7.6
0.01
29
181
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
228
1.65
2.14
2.2
2.2
g/l
3.9
3.6
1.12
28
176
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
228
1.65
2.14
2.2
2.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
17
81
2.12
2.13
4.1
3.3
%
2.0
1.0
0.26
12
62
(3026493) Urate [Moles/volume] in Serum or Plasma
199
1656
1.26
2.12
2.2
2.4
umol/l
306.8
5975.1
6.27
174
1435
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
29
168
1.75
2.10
1.6
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
25
3.22
2.10
1.1
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
214
1.66
2.09
2.3
2.2
g/l
3.1
3.2
0.03
28
179
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
21
110
1.93
2.07
1.6
1.7
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
20
3.52
2.06
1.7
2.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
26
147
1.79
2.04
1.5
1.4
u/ml
214.0
246.6
0.30
20
87
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
22
118
1.89
2.03
1.1
1.0
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
13
57
2.30
1.98
7.6
5.4
mg/l
13.5
11.9
0.60
13
52
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
27
2.98
1.94
1.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
42
276
1.55
1.90
2.4
2.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
24
136
1.79
1.88
1.2
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
24
136
1.79
1.88
1.2
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
42
278
1.54
1.85
1.5
1.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
45
303
1.51
1.83
4.6
3.2
mmol/l
24.9
24.2
0.66
39
269
(3002032) Base excess in Venous blood by calculation
75
557
1.38
1.83
3.8
3.1
mmol/l
2.3
2.1
0.16
62
444
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
28
169
1.68
1.79
2.1
3.7
u/ml
0.4
0.4
—
10
99
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
14
67
2.11
1.76
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
14
67
2.11
1.76
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
14
67
2.11
1.76
1.3
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
39
257
1.54
1.76
1.5
2.2
g/l
1.5
1.5
0.15
32
225
(3042631) Mycobacterium sp identified in Specimen
15
74
2.04
1.75
1.7
2.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
82
623
1.35
1.74
3.1
3.7
ug/l
13.3
10.5
0.13
60
493
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
209
1788
1.22
1.72
2.6
2.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
45
309
1.48
1.69
1.8
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
45
309
1.48
1.69
1.9
1.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
18
97
1.87
1.67
1.2
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
19
3.17
1.66
1.7
3.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
289
2558
1.19
1.66
1.7
1.7
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
28
173
1.64
1.65
1.1
1.1
u/ml
13.3
3.9
0.81
15
86
(3035933) Granulocytes/100 leukocytes in Blood
7
25
2.81
1.65
1.3
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
21
120
1.77
1.63
2.6
4.5
—
—
—
0
0
(3020891) Body temperature
35
230
1.54
1.62
4.2
4.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
54
388
1.42
1.62
1.4
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
14
3.58
1.61
1.2
2.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
90
704
1.31
1.59
32.7
23.5
inr
1.3
1.2
—
9
104
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
31
199
1.58
1.58
1.5
1.6
—
108.6
—
0
7
(3004451) EKG impression Narrative
7
26
2.71
1.58
1.6
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
51
365
1.42
1.57
1.9
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
54
391
1.41
1.56
1.8
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
78
1.94
1.55
1.3
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
15
78
1.94
1.55
1.1
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
11
51
2.17
1.51
1.1
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
54
394
1.39
1.50
1.9
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
24
147
1.65
1.48
2.2
2.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
28
2.51
1.45
1.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
28
2.51
1.45
1.1
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
49
354
1.41
1.45
4.3
4.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
52
2.13
1.45
1.4
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
71
545
1.33
1.44
3.0
2.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
54
397
1.38
1.44
1.9
1.7
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
13
66
1.98
1.44
1.5
2.0
pg
28.6
31.0
0.75
13
66
(3000492) Spirometry study
84
661
1.30
1.44
1.7
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
39
2.32
1.43
1.4
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
20
118
1.71
1.42
1.2
1.0
u/ml
15.7
8.0
—
8
40
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
66
504
1.33
1.40
1.1
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
29
2.42
1.39
1.1
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
9
41
2.21
1.37
1.6
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
23
143
1.62
1.36
1.4
1.4
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
37
0.00
1.34
0.0
2.4
—
52.5
—
0
28
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
11
54
2.05
1.33
1.2
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
56
421
1.35
1.32
1.5
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
32
217
1.49
1.32
1.1
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
43
2.10
1.30
1.1
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
23
145
1.60
1.30
1.3
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
19
114
1.68
1.29
2.7
1.9
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
11
55
2.01
1.27
1.2
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
11
55
2.01
1.27
1.2
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
752
7275
1.20
1.25
4.2
3.9
mmol/l
1.5
1.6
2.84
707
6758
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
36
2.23
1.24
2.8
3.0
u/ml
369.3
1292.7
—
8
36
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
25
163
1.55
1.24
2.6
4.2
mg/l
1.5
1.4
0.21
25
146
(3000764) Benzodiazepines [Presence] in Urine
52
392
1.35
1.22
2.0
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
71
560
1.29
1.22
1.4
1.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
10
49
2.05
1.22
5.8
6.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
756
7321
1.20
1.22
4.3
3.9
mmol/l
4.7
4.8
2.66
719
6822
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
19
2.64
1.21
1.2
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
19
2.64
1.21
1.0
1.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
5
19
2.64
1.21
1.0
1.1
—
66.5
—
0
6
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
13
71
1.84
1.20
1.2
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
25
165
1.53
1.18
1.0
1.1
u/ml
0.7
0.7
0.06
13
68
(3051651) Icteric interference index of Serum or Plasma
8
38
2.11
1.18
2.4
3.7
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
48
361
1.35
1.16
1.9
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
19
118
1.62
1.15
1.8
1.8
—
—
—
0
0
(3000012) Reticulocyte production index
8
39
2.06
1.15
1.0
1.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
13
72
1.82
1.15
1.1
1.0
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
28
191
1.48
1.15
1.2
1.1
u/ml
0.7
2.1
0.86
12
67
(3002179) Metamyelocytes/100 leukocytes in Blood
68
540
1.28
1.12
4.6
3.6
%
0.3
0.6
0.90
18
95
(3023511) Choriogonadotropin [Units/volume] in Urine
50
381
1.33
1.11
1.5
1.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
10
51
1.97
1.11
1.1
1.1
ratio
1.0
1.1
—
5
23
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
32
226
1.43
1.11
1.5
1.2
u/ml
3.3
9.0
—
5
43
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
73
1.79
1.11
1.1
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
5
21
2.39
1.09
1.2
2.0
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
5
21
2.39
1.09
1.2
2.1
%
7.2
4.2
—
5
21
(3005033) Fetal Nuchal fold Thickness US
53
409
1.31
1.09
1.5
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
21
137
1.55
1.06
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
21
137
1.55
1.06
1.0
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
33
237
1.41
1.06
1.5
1.6
iu/ml
0.0
0.3
—
8
41
(3047352) Trisomy 18 risk [Likelihood] in Fetus
53
412
1.30
1.04
1.5
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
22
2.28
1.03
2.8
1.2
ug/l
8.0
8.5
—
5
22
(4024509)
13
75
1.74
1.03
1.6
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
69
557
1.26
1.02
4.9
3.9
%
0.0
0.1
3.07
21
123
(3010726) Horse dander IgE Ab [Units/volume] in Serum
23
155
1.50
1.02
1.2
1.0
u/ml
1.2
1.8
—
5
30
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
115
1.58
1.00
1.2
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
765
7446
1.17
1.00
4.9
4.4
mmol/l
2.7
2.8
2.26
719
6899
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
13
76
1.72
0.99
1.6
1.8
%
42.5
57.8
—
8
44
(3047189) Immunofixation for 24 hour Urine
5
23
2.18
0.98
1.6
1.7
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
5
23
2.18
0.98
1.2
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
17
108
1.59
0.97
1.2
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
50
1.81
0.96
1.1
1.6
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
12
69
1.75
0.96
1.2
1.2
u/ml
0.0
1.3
—
6
24
(3025159) Blasts/100 leukocytes in Blood
66
534
1.25
0.96
5.0
4.0
%
0.0
0.9
0.55
19
101
(3034274) Bile acid [Moles/volume] in Serum --fasting
28
199
1.42
0.96
1.6
2.1
umol/l
5.5
4.5
0.26
22
144
(4094501)
22
149
1.49
0.96
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
101
1.59
0.94
1.2
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
717
6955
1.15
0.93
3.8
3.5
mmol/l
1.2
1.2
1.02
666
6423
(44816559) Phosphatidylethanol [Mass/volume] in Blood
19
126
1.52
0.91
1.1
1.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
11
63
1.76
0.90
1.5
1.5
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
26
185
1.42
0.90
1.4
1.2
u/ml
25.1
34.3
—
5
22
(3036071) Salmonella sp Ab [Titer] in Serum
6
29
2.08
0.89
1.3
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
8
42
1.91
0.88
4.6
2.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
48
378
1.28
0.88
2.1
1.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
18
119
1.52
0.88
1.2
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
13
79
1.65
0.88
2.8
2.2
mg/l
28.8
17.9
—
5
23
(3021901) Oxygen saturation in Capillary blood
14
87
1.62
0.88
4.4
2.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
103
1.56
0.88
1.4
1.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
20
136
1.48
0.87
1.2
1.0
u/ml
3.9
6.7
—
7
44
(3017181) Myelocytes/100 leukocytes in Blood
71
588
1.23
0.86
4.8
3.8
%
0.5
0.9
0.88
21
138
(44813793)
11
64
1.73
0.86
1.1
1.0
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
6
31
1.94
0.84
1.2
2.3
e9/l
0.1
0.1
—
6
31
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
65
1.70
0.82
1.4
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
97
1.56
0.81
1.3
1.4
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
33
1.82
0.79
1.0
1.6
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
45
358
1.27
0.78
3.1
2.6
g/l
127.6
127.4
0.03
45
350
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
68
568
1.21
0.78
2.1
2.5
ml/min/173m2
69.5
69.5
0.00
27
215
(1002224) Polysomnography panel
36
279
1.30
0.77
1.0
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
9
53
1.70
0.75
1.1
1.2
—
222.5
—
0
12
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
94
812
1.18
0.75
7.4
6.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
30
227
1.33
0.75
1.8
1.8
—
—
—
0
0
(44806118)
11
67
1.65
0.75
1.3
1.4
—
—
—
0
0
(44790049)
11
67
1.65
0.75
1.3
1.4
—
—
—
0
0
(44790047)
11
67
1.65
0.75
1.3
1.4
—
—
—
0
0
(44790048)
11
67
1.65
0.75
1.3
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
54
1.67
0.74
1.6
1.4
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
7
38
1.85
0.73
1.0
1.0
ng/l
625.1
669.9
—
7
24
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
49
398
1.24
0.73
1.4
1.3
miu/ml
187.1
244.5
0.66
25
197
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
18
125
1.45
0.73
1.0
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
5
25
2.01
0.72
1.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
9
56
1.61
0.72
5.8
2.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
13
84
1.56
0.72
1.1
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
40
1.76
0.71
1.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
27
1.86
0.68
1.0
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
86
1.52
0.66
1.1
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
10
62
1.62
0.65
1.2
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
44
1.60
0.65
1.0
2.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
44
1.60
0.65
1.1
1.4
—
—
—
0
0
(4281824)
14
95
1.48
0.64
1.1
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
27
207
1.31
0.64
2.7
2.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
34
270
1.27
0.63
1.9
2.0
iu/l
4.2
5.0
0.31
13
105
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
49
1.64
0.62
1.5
1.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
18
130
1.39
0.61
1.2
1.0
u/ml
1.4
2.1
—
8
62
(21494890) Protein electrophoresis panel - 24 hour Urine
8
50
1.61
0.61
1.8
2.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
13
88
1.48
0.60
1.1
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
21
0.00
0.60
0.0
15.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
52
1.54
0.59
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
21
157
1.35
0.59
1.3
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
18
131
1.38
0.59
1.5
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
53
1.51
0.58
2.9
2.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
53
1.51
0.58
3.8
3.8
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
11
161
0.68
0.57
5.5
3.2
mg/l
33.0
25.6
—
6
96
(3019230) Fractional oxyhemoglobin in Venous blood
13
90
1.45
0.55
4.9
1.8
%
60.9
60.2
0.04
13
90
(3021788) Differential panel - Synovial fluid
16
116
1.39
0.54
1.9
1.9
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
6
38
1.58
0.54
2.0
3.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
61
1.48
0.53
1.1
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
9
62
1.46
0.53
1.0
1.2
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
9
62
1.46
0.53
3.9
1.6
mmol/l
6.3
6.9
—
9
44
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
9
63
1.43
0.52
1.1
1.1
—
—
—
0
0
(3036603) Volume of Urine
6
40
1.50
0.51
1.5
1.6
—
2458.4
—
0
8
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
64
1.41
0.51
1.6
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
6
41
1.47
0.50
1.0
1.1
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
6
41
1.47
0.50
1.2
1.4
pmol/l
16.4
13.9
—
6
33
(4034850)
27
216
1.26
0.50
8.3
8.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
10
67
1.50
0.50
1.4
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
67
1.50
0.50
1.2
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
14
101
1.39
0.49
1.4
1.7
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
58
503
1.16
0.49
1.5
1.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
16
119
1.35
0.48
3.2
2.5
ug/min
57.2
92.5
0.23
11
76
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
58
505
1.16
0.47
1.5
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
43
504
0.85
0.47
1.3
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
10
68
1.48
0.47
1.2
2.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
12
85
1.42
0.47
1.3
1.3
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
7
48
1.46
0.47
1.0
1.0
mg/l
280.6
302.2
—
7
39
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
58
506
1.16
0.46
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
58
506
1.16
0.46
1.5
1.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
17
129
1.32
0.46
1.2
1.6
mmol/l
6.2
7.1
0.72
12
88
(3005570) Glucose [Moles/volume] in Urine
5
83
0.60
0.46
3.0
2.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
77
1.43
0.45
1.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
12
86
1.40
0.44
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
51
1.38
0.44
3.4
3.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
18
140
1.29
0.42
1.6
1.9
e6/l
5326.1
17921.0
1.41
12
97
(3027273) Bicarbonate [Moles/volume] in Venous blood
33
277
1.20
0.41
2.3
2.7
mmol/l
25.3
25.4
0.07
33
268
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
1.4
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
1.4
1.5
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
18
0.00
0.40
0.0
1.1
—
39.7
—
0
9
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
30
251
1.20
0.39
2.0
1.9
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
35
1.43
0.39
1.0
1.1
iu/ml
107.4
154.5
—
5
35
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
18
142
1.27
0.38
2.9
2.4
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
9
66
1.37
0.38
1.0
1.1
mg/l
172.3
199.8
—
9
57
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
36
1.39
0.38
1.0
1.4
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
9
69
1.31
0.37
1.0
1.2
mg/l
35.0
29.5
—
9
53
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
19
152
1.26
0.37
1.8
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
72
1.39
0.37
1.2
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
38
328
1.17
0.36
3.1
3.5
ph
7.4
7.4
—
9
45
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
79
0.63
0.35
1.6
2.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
91
1.32
0.34
1.3
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
22
182
1.21
0.33
5.3
3.9
mmol/l
3.8
3.8
0.10
22
169
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
88
0.68
0.33
1.2
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
64
706
0.90
0.33
1.4
1.5
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
12
92
1.31
0.32
3.7
3.3
u/ml
18.6
61.1
1.44
12
92
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
84
1.31
0.30
1.7
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
84
1.31
0.30
1.7
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
84
1.31
0.30
1.7
1.2
—
—
—
0
0
(4027681)
7
57
1.23
0.29
1.0
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
57
1.23
0.29
1.1
1.5
g/l
0.9
1.0
—
7
57
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
57
1.23
0.29
1.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
47
422
1.12
0.28
1.5
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
33
375
0.88
0.28
1.4
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
16
131
1.23
0.27
1.4
1.5
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
9
74
1.22
0.25
1.1
1.1
g/l
1.4
1.4
—
9
68
(3041354) Potassium [Moles/volume] in Venous blood
6
81
0.74
0.24
1.5
2.0
mmol/l
4.1
4.0
—
6
81
(3035285) Chloride [Moles/volume] in Venous blood
6
81
0.74
0.24
1.5
2.0
mmol/l
105.5
105.7
—
6
81
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
35
313
1.12
0.23
2.7
3.6
mmol/l
2.3
1.7
0.45
26
233
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
1.4
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
59
544
1.09
0.23
1.9
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
79
1.27
0.22
1.4
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
60
556
1.08
0.21
1.5
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
42
1.19
0.21
1.8
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
42
1.19
0.21
1.8
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
42
1.19
0.21
1.8
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
42
1.19
0.21
1.2
1.6
%
7.8
10.7
—
5
42
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
33
296
1.12
0.21
2.3
2.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.3
—
1.3
—
0
11
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
11
0.00
0.21
0.0
4.4
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
10
0.00
0.21
0.0
5.5
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
43
1.16
0.21
1.0
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
48
1.25
0.20
1.2
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
49
1.23
0.20
1.0
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
15
127
1.18
0.19
3.1
3.4
nmol/l
0.7
0.8
—
9
99
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
58
1.21
0.18
1.3
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
12
100
1.20
0.18
2.5
2.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
24
215
1.12
0.16
1.7
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
83
1.09
0.14
1.9
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
20
179
1.12
0.14
5.2
4.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
80
837
0.95
0.14
4.6
3.9
%
34.2
33.5
0.24
58
568
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
84
1.19
0.14
1.8
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
84
1.19
0.14
1.8
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
72
755
0.95
0.13
1.2
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
15
132
1.14
0.13
2.1
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
113
1.15
0.13
1.6
1.3
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
11
127
0.86
0.12
2.5
2.0
%
13.5
13.1
0.40
11
127
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
41
435
0.94
0.11
1.6
1.7
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
11
126
0.87
0.11
1.6
1.5
—
—
—
0
0
(3019225) pH of Specimen
68
652
1.05
0.11
3.5
3.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
21
229
0.92
0.11
2.4
3.8
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
12
135
0.89
0.10
1.2
1.7
mmol/l
6.5
7.3
—
7
81
(3000330) Specific gravity of Urine by Test strip
42
399
1.06
0.09
4.3
3.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
25
233
1.08
0.09
1.1
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
40
380
1.06
0.09
2.4
1.7
mg/l
3.9
4.2
0.07
29
261
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
54
1.11
0.09
1.2
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
66
1.06
0.08
1.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
77
1.04
0.07
1.1
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
61
624
0.98
0.04
1.5
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
13
121
1.08
0.03
5.1
2.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
98
967
1.02
0.03
1.4
1.5
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
12
128
0.94
0.02
3.3
2.5
mmol/l
7.5
7.4
0.07
12
128
(3008037) Lactate [Moles/volume] in Venous blood
13
136
0.96
0.00
3.2
2.4
mmol/l
1.3
1.5
0.43
13
136
(1761868) Lipid panel - Serum or Plasma
262
2618
1.00
0.00
2.9
2.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
15
153
0.98
0.00
1.7
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
47
465
1.01
0.00
1.3
1.5
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
8.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
7
0.00
0.00
0.0
8.1
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
20.3
—
0
5
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
86.6
—
0
5
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
23
230
1.00
0.00
3.4
2.7
g/l
0.2
0.3
1.26
12
85
(3005082) Progesterone [Moles/volume] in Serum or Plasma
8
83
0.96
0.00
1.3
1.3
nmol/l
49.2
33.0
—
8
73
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
7.8
—
0
5
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.2
—
3.3
—
0
6
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
6.3
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
7
0.00
0.00
0.0
3.3
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
0
9
0.00
0.00
0.0
1.1
—
25.0
—
0
9
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
8.1
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.8
—
2.9
—
0
5
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
9
89
1.01
0.00
3.1
1.9
u/ml
3.6
55.7
—
9
76
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.0
—
8.0
—
0
5
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
34.5
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint N14_ULCERVAGVUL and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| N14_ULCERVAGVUL | 1.353 [1.16, 1.58] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.025 |
During the follow-up period (1.1.1998 — 31.12.2019), 484 out of 4215 females with N14_ULCERVAGVUL died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have N14_ULCERVAGVUL.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.134% | No data |
| 5 | 0.701% | No data |
| 10 | 1.616% | No data |
| 15 | 3.088% | No data |
| 20 | 5.684% | No data |
Relationships between endpoints
↥Index endpoint: N14_ULCERVAGVUL – Ulcer of vagina/vulva
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data